Regeneron Strikes Drug Pricing Deal With Trump, Will Offer New Hearing-Loss Therapy for Free

Regeneron Pharmaceuticals on April 23 became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States. President Donald Trump announced the deal from the Oval Office. “With this announcement, 17 of the world’s largest pharmaceutical companies, representing 80 percent of the branded drug market, have now agreed to sell their drugs to American patients at the lowest prices anywhere in the world,” Trump said. With Regeneron’s agreement, all of the pharmaceutical CEOs that Trump directly asked to join the Most Favored Nation pricing model have responded favorably. Trump has said his aim in making the deals is to correct the long-standing practice by pharmaceutical companies of charging Americans about three times more for prescription medications than those in other countries....